Duramed gets FDA OK on Seasonique

Duramed Pharmaceuticals has received FDA approval for Seasonique, an extended cycle contraceptive that should hit the markets in July. Seasonique's low-dose estrogen pills--which limit menstrual cycles to four times a year--replace a series of placebos in the monthly cycle that researchers say will help limit bloating and hormonal fluctuations.

- read the report from the Kaiser Network

Suggested Articles

Out of options, Tocagen will become Forte Biosciences’ route to the public markets through an all-stock reverse merger.

Reich co-founded Effector and served as its SVP of research but has moved on to take up the CSO position at Turning Point Therapeutics.

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval.